Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Cash: 2015-2024

Historic Change in Cash for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $87.1 million.

  • Anaptysbio's Change in Cash fell 45.28% to $65.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.7 million, marking a year-over-year decrease of 149.46%. This contributed to the annual value of $87.1 million for FY2024, which is 346.48% up from last year.
  • Latest data reveals that Anaptysbio reported Change in Cash of $87.1 million as of FY2024, which was up 346.48% from -$35.3 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Change in Cash registered a high of $245.2 million during FY2021, and its lowest value of -$424.4 million during FY2022.
  • Over the past 3 years, Anaptysbio's median Change in Cash value was -$35.3 million (recorded in 2023), while the average stood at -$124.2 million.
  • As far as peak fluctuations go, Anaptysbio's Change in Cash crashed by 273.08% in 2022, and later skyrocketed by 346.48% in 2024.
  • Yearly analysis of 5 years shows Anaptysbio's Change in Cash stood at $79.4 million in 2020, then spiked by 208.68% to $245.2 million in 2021, then plummeted by 273.08% to -$424.4 million in 2022, then skyrocketed by 91.67% to -$35.3 million in 2023, then skyrocketed by 346.48% to $87.1 million in 2024.